These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6824571)

  • 81. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
    Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
    Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum oestradiol-17 beta in normal women.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Jun; 29(6):462-9. PubMed ID: 4854260
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Serum oestradiol in women with and without breast disease.
    Bennett IC; McCaffrey JF; McCaffrey E; Wyatt B
    Br J Cancer; 1990 Jan; 61(1):142-6. PubMed ID: 2393409
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
    Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Correlation between changes in prolactin and melatonin serum levels after radical mastectomy.
    Lissoni P; Paolorossi F; Barni S; Tancini G; Crispino S; Rovelli F; Ferri L; Esposti G; Esposti D; Fraschini F
    Tumori; 1987 Jun; 73(3):263-7. PubMed ID: 3603722
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prolactin levels in populations at risk for breast cancer.
    Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
    Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prognostic significance of serum prolactin levels in advanced breast cancer.
    Dowsett M; McGarrick GE; Harris AL; Coombes RC; Smith IE; Jeffcoate SL
    Br J Cancer; 1983 Jun; 47(6):763-9. PubMed ID: 6860546
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
    Love RR; Rose DR; Surawicz TS; Newcomb PA
    Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cyproterone acetate in the treatment of metastatic cancer of the male breast.
    Lopez M
    Cancer; 1985 May; 55(10):2334-6. PubMed ID: 3986737
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A prospective study of plasma prolactin levels and subsequent risk of breast cancer.
    Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J
    Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Steroid hormones in lymph and blood from women with early breast cancer.
    Hamed H; Caleffi M; Fentiman IS; Thomas B; Bulbrook RD
    Eur J Cancer; 1991; 27(1):42-4. PubMed ID: 1826439
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Plasma prolactin as an indicator of disease progression in advanced breast cancer.
    Bhatavdekar JM; Shah NG; Balar DB; Patel DD; Bhaduri A; Trivedi SN; Karelia NH; Ghosh N; Shukla MK; Giri DD
    Cancer; 1990 May; 65(9):2028-32. PubMed ID: 2372769
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer.
    Schenker JG; Weinstein D; Okon E
    Cancer; 1979 Nov; 44(5):1809-12. PubMed ID: 498050
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk.
    Wang DY; Sturzaker HE; Kwa HG; Verhofstad F; Hayward JL; Bulbrook RD
    Int J Cancer; 1984 May; 33(5):629-32. PubMed ID: 6724738
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A novel case of a raised testosterone and LH in a young man.
    McDonald TJ; Perry MH; Jones AG; Donohoe M; Salzmann MB; O'Connor J
    Clin Chim Acta; 2011 Oct; 412(21-22):1999-2001. PubMed ID: 21756889
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prolactin and breast cancer.
    Wang DY
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):147-8. PubMed ID: 2920763
    [No Abstract]   [Full Text] [Related]  

  • 99. Reduced plasma LH concentration in postmenopausal depressed women.
    Altman N; Sachar EJ; Gruen PH; Halpern JS; Eto S
    Psychosom Med; 1975; 37(3):274-6. PubMed ID: 1178796
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Plasma prolactin levels and age in a female population: relation to breast cancer.
    Bulbrook RD; Wang DY; Hayward JL; Kwa HG; Cleton F
    Int J Cancer; 1981 Jul; 28(1):43-5. PubMed ID: 7309281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.